Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Earnings for Pulse Biosciences, Inc. (PLSE)
Earnings in 2023 (TTM): $-42,210,000
According to Pulse Biosciences, Inc.'s latest financial reports the company's current earnings (TTM) are $-42,210,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Pulse Biosciences, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-42,210,000 | $-42,210,000 |
| 2022 | $-58,505,000 | $-58,953,000 |
| 2021 | $-63,660,000 | $-63,160,000 |
| 2020 | $-49,851,000 | $-49,737,000 |
| 2019 | $-46,971,000 | $-45,988,000 |
| 2018 | $-37,545,000 | $-37,545,000 |
| 2017 | $-25,567,000 | $-25,567,000 |
| 2016 | $-9,518,000 | $-9,518,000 |
| 2015 | $-4,467,949 | $-2,811,283 |
| 2014 | $-514,286 | $-474,857 |